1-20 of 658 Search Results for

prescription drug policy

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Article
J Health Polit Policy Law (2021) 46 (6): 1053–1068.
Published: 01 December 2021
...Rachel E. Sachs Abstract Throughout his four years in office, President Trump made prescription drug pricing a focus of his policy agenda. President Trump not only used strong language to criticize the pharmaceutical industry and its practices but also introduced ambitious reform policies that had...
Journal Article
J Health Polit Policy Law (2007) 32 (1): 89–129.
Published: 01 February 2007
... in delaying prescription drug coverage at the national level seemingly incapable of stopping the majority of states from passing the same kinds of legislation? To answer this question, we develop and test a number of hypotheses about the determinants of health policy using Heckman models with data...
Journal Article
J Health Polit Policy Law (2010) 35 (5): 705–742.
Published: 01 October 2010
... government's role in the area of prescription drugs; (2) describing the policymaking process; (3) identifying factors in each province's choice of a policy; (4) identifying patterns in those factors across the five provinces; and (5) assessing the federal government's influence on the policies chosen. Analysis...
Journal Article
J Health Polit Policy Law (2021) 46 (4): 599–609.
Published: 01 August 2021
... coverage. These policies could provide important financial protections for Americans against high prescription drug prices. Despite widespread public support for addressing prescription drug prices, many of Biden's plans rely on congressional action, which will be complicated by the narrow majority held...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 853–877.
Published: 01 December 2022
...Erin Trish; Katrina M. Kaiser; Jeanai Celestin; Geoffrey Joyce Abstract Context: Reforming the Medicare Part D program—which provides prescription drug coverage to 49 million beneficiaries—has emerged as a key policy priority. Methods: The authors evaluate prescription drug claims from a 100...
FIGURES | View All (8)
Journal Article
J Health Polit Policy Law (2008) 33 (6): 1079–1106.
Published: 01 December 2008
..., Improvement, and Modernization Act. Journal of Health Politics, Policy and Law 32 : 187 -219. Oliver, R., P. Lee, and H. Lipton. 2004 . A Political History of Medicare and Prescription Drug Coverage. Milbank Quarterly 82 : 283 -354. Olson, M. 1965 . The Logic of Collective Action . Cambridge...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 709–729.
Published: 01 December 2022
... infrastructure, patient and prescriber characteristics, as well as health policy determinants of inequitable medication access. In this article, the authors describe these determinants, identify drivers of ongoing inequities in prescription drug access, and provide a framework for the path toward achieving...
FIGURES
Journal Article
J Health Polit Policy Law (2013) 38 (3): 475–477.
Published: 01 June 2013
... others related to prescription drug policy. For example, the article by Denis Arnold and James Oakley examines US policy toward direct-­to-­consumer advertising (DTCA). Essentially, the US government relies on industry self-­regulation to determine appropriate ethical standards and practices...
Journal Article
J Health Polit Policy Law (2014) 39 (2): 295–330.
Published: 01 April 2014
... coverage of prescription drug financing from 1990 to 2010 to elucidate how the policy problem and potential solutions have been framed in media discourse and identify the actors that have dominated media texts. We confirm previous analyses that have revealed the significant role played by policy elites...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 673–690.
Published: 01 December 2022
... Administration accelerated approval drug pricing The impact of drug coverage and pricing policies on state Medicaid programs and state budgets is an understudied area within prescription drug pricing debates. Unlike the federal government, nearly all states have a balanced budget requirement, though...
FIGURES
Includes: Supplementary data
Journal Article
J Health Polit Policy Law (2024) 49 (2): 249–268.
Published: 01 April 2024
... Classification index to identify the classes of prescription drugs implicated in fraud actions. Findings: During fiscal years 2006–2022, payments by six manufacturers amounted to more than 28% of total payments made as a result of federal False Claims Act actions. Nervous system and cardiovascular drugs were...
FIGURES | View All (8)
Journal Article
J Health Polit Policy Law (2011) 36 (2): 295–316.
Published: 01 April 2011
...Patricia M. Danzon; Scott J. Johnson; Genia Long; Michael F. Furukawa The option of legalizing the commercial importation of prescription drugs is of continued policy interest as a way to reduce U.S. drug spending. Using IMS data, we estimate potential savings from commercial drug importation under...
Journal Article
J Health Polit Policy Law (2011) 36 (6): 961–973.
Published: 01 December 2011
...-provided health insurance, and the Medicare Part D prescription drug program — demonstrate how policy designs affect subsequent policy outcomes. To differing degrees, the three cases show how public policies can create constituencies with particular understandings of their benefits who attempt to thwart...
Journal Article
J Health Polit Policy Law (2013) 38 (3): 505–544.
Published: 01 June 2013
... . Calfee John E. 2002 . “Public Policy Issues in Direct-to-Consumer Advertising of Prescription Drugs.” Journal of Public Policy and Marketing 21 , no. 2 : 174 – 93 . Capella Michael L. . 2009 . “Do Pharmaceutical Marketing Activities Raise Prices? Evidence from Five Major...
Journal Article
J Health Polit Policy Law (2006) 31 (5): 887–944.
Published: 01 October 2006
... positions and enhance their influence over policy making. Evidence is drawn from statistical analysis of 263 interviews with health policy elites and a qualitative case study of the debate over the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. The results explain, in part, how...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 621–628.
Published: 01 December 2022
... for these beneficiaries. Taken together, these measures represent a transformative moment in US prescription drug policy. The IRA also represents a major political defeat for the pharmaceutical industry, which opposed these reforms. Still, the scope of the new law is limited. Opposition from Republicans...
Journal Article
J Health Polit Policy Law (2005) 30 (4): 779–784.
Published: 01 August 2005
... the University of California, Berkeley. He recently completed a postdoctoral fellowship at the Centre for Health Services and Policy Research at the University of British Columbia. His research interests include prescription drug policy, comparative health policy, and health politics. Andrea K. Biddle...
Journal Article
J Health Polit Policy Law (2007) 32 (2): 187–219.
Published: 01 April 2007
...Jonathan Oberlander The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) represents a watershed event in Medicare politics. This essay explores the political lessons and policy legacies of the MMA, focusing on how the MMA fits with and deviates from established patterns...
Journal Article
J Health Polit Policy Law (2019) 44 (5): 765–787.
Published: 01 October 2019
..., and Magazines Predicts Black and White Adolescents' Sexual Behavior .” Pediatrics 117 , no. 4 : 1018 – 27 . Calfee John E. 2002 . “ Public Policy Issues in Direct-to-Consumer Advertising of Prescription Drugs .” Journal of Public Policy and Marketing 21 , no. 2 : 174 – 93 . Chandra...
FIGURES | View All (4)
Journal Article
J Health Polit Policy Law (2012) 37 (3): 567–570.
Published: 01 June 2012
... at Southern Illinois University in Edwardsville, received her PhD at the University of Missouri in St. Louis. Her major field of study is policy analysis, with a concentration on health policy. Other areas of interest include state prescription drug policies, health care policy and policy analy- sis...